yahoo_financeOriginal article
Opus Genetics Says FDA Approves Supplemental Application for Presbyopia Treatment
RegulatoryapprovedPhentolamine Ophthalmic SolutionPositive
AI Analysis
Summary
Opus Genetics announced that the FDA approved a supplemental application for its presbyopia treatment. Specific details of the approved change were not provided in the available text.
Outcome Details
FDA approved a supplemental application for the presbyopia treatment. Only the headline was available; no further details provided.
Importance:6/10
Sentiment:
0.60
FDA approvalsupplemental applicationpresbyopiaophthalmology
Read the original article
Published by yahoo_finance on October 16, 2026 5:37 PM